ArticleFood science & nutrition2026
Beneficial Impact of Kaempferol on Kidney Function and Long-Term Prognosis in Overweight or Obese Adults.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review.Journal of cancer prevention · 2026Review
- Baicalin as a multifunctional flavone glycoside: pharmacological mechanisms, ADME profile, and therapeutic potential.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Beneficial Impact of Kaempferol on Kidney Function and Long-Term Prognosis in Overweight or Obese Adults.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a significant risk factor for chronic kidney disease (CKD). Kaempferol, a natural flavonoid, has the ability to alleviate oxidative stress in animal models. The aim of this study is to assess the relationship between kaempferol intake and renal function, as well as its impact on long-term prognosis in the obese population. This is an observational, cross-sectional, and longitudinal analysis based on NHANES data (2007-2018). Data regarding flavanol consumption were obtained from FNDDS. Prognostic information was sourced from the NCHS. Multivariate logistic and Cox regression, subgroup, and sensitivity analysis were used to investigate the relationship between dietary kaempferol and kidney function and prognosis. A total of 9816 participants with a median follow-up of 117 months were included. The stratified analysis revealed that kaempferol was a protective factor for renal function. For every 5 mg/day increment in kaempferol intake, the prevalence of kidney damage declined by 7% [OR = 0.93, 95% CI: 0.88-0.99]. Additionally, at a median follow-up duration of 117 months, for every 5 mg/day increase in kaempferol intake, the mortality rate decreased by 7% [HR = 0.93, 95% CI: 0.85-0.98]. Our findings suggested that higher kaempferol intake is associated with a reduced risk of kidney damage and improved long-term prognosis in obese individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.